Masashi Tachibana

Masashi Tachibana

Auto-generated profile, based on publicly available information

Masashi Tachibana

Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Biomaterials
Verified
Journal Article
Closed access
KTKazuo Takayama
Kazuo Takayama
KKKenji Kawabata
Kenji Kawabata
YNYasuhito Nagamoto
Yasuhito Nagamoto
KKKeisuke Kishimoto
Keisuke Kishimoto
KTKatsuhisa Tashiro
Katsuhisa Tashiro
HMHiroyuki Mizuguchi
Hiroyuki Mizuguchi

8 February 2008 in Science
Verified
Journal Article
Closed access
PDF file
RSRuka Setoguchi
Ruka Setoguchi
MTMasashi Tachibana
Masashi Tachibana
YNYoshinori Naoe
Yoshinori Naoe
SMSawako Muroi
Sawako Muroi
KAKaori Akiyama
Kaori Akiyama
ITIchiro Taniuchi
Ichiro Taniuchi
Mouse CD4 + CD8 + double-positive (DP) thymocytes differentiate into CD4 + helper-lineage cells upon expression of the transcription factor Th-POK but commit to the CD8 + cytotoxic lineage in its absence. We report the redirected differentiation of class I–restricted thymocytes into CD4 + CD8 – helper-like T cells upon loss of Runx transcription factor complexes. A Runx-binding sequence within the Th-POK locus acts as a transcriptional silencer that is essential for Th-POK repression and for development of CD8 + T cells. Thus, Th-POK expression and genetic programming for T helper cell development are actively inhibited by Runx-dependent silencer activity, allowing for cytotoxic T cell differentiation. Identification of the transcription factors network in CD4 and CD8 lineage choice provides insight into how distinct T cell subsets are developed for regulating the adaptive immune system.

9 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
KFKento Fujiwara
Kento Fujiwara
ATAyaka Tsunei
Ayaka Tsunei
HKHotaka Kusabuka
Hotaka Kusabuka
EOErika Ogaki
Erika Ogaki
MTMasashi Tachibana
Masashi Tachibana
NONaoki Okada
Naoki Okada
Chimeric antigen receptor (CAR)-T cells have demonstrated significant clinical potential; however, their strong antitumor activity may cause severe adverse effects. To ensure efficacy and safe CAR-T cell therapy, it is important to understand CAR’s structure–activity relationship. To clarify the role of hinge and transmembrane domains in CAR and CAR-T cell function, we generated different chimeras and analyzed their expression levels and antigen-specific activity on CAR-T cells. First, we created a basic CAR with hinge, transmembrane, and signal transduction domains derived from CD3ζ, then we generated six CAR variants whose hinge or hinge/transmembrane domains originated from CD4, CD8α, and CD28. CAR expression level and stability on the T cell were greatly affected by transmembrane rather than hinge domain. Antigen-specific functions of most CAR-T cells depended on their CAR expression levels. However, CARs with a CD8α- or CD28-derived hinge domain showed significant differences in CAR-T cell function, despite their equal expression levels. These results suggest that CAR signaling intensity into T cells was affected not only by CAR expression level, but also by the hinge domain. Our discoveries indicate that the hinge domain regulates the CAR signaling threshold and the transmembrane domain regulates the amount of CAR signaling via control of CAR expression level.

10 November 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KTKazuo Takayama
Kazuo Takayama
YMYuta Morisaki
Yuta Morisaki
SKShuichi Kuno
Shuichi Kuno
YNYasuhito Nagamoto
Yasuhito Nagamoto
KHKazuo Harada
Kazuo Harada
HMHiroyuki Mizuguchi
Hiroyuki Mizuguchi
Significance: We found that individual cytochrome P450 (CYP) metabolism capacity and drug sensitivity could be predicted by examining them in the primary human hepatocytes–human induced pluripotent stem cells–hepatocyte-like cells (PHH-iPS-HLCs). We also confirmed that interindividual differences of CYP metabolism capacity and drug responsiveness that are due to the diversity of individual single nucleotide polymorphisms in the CYP gene could also be reproduced in the PHH-iPS-HLCs. These findings suggest that interindividual differences in drug metabolism capacity and drug response could be predicted by using HLCs differentiated from human iPS cells. We believe that iPS-HLCs would be a powerful technology not only for accurate and efficient drug development, but also for personalized drug therapy.

1 August 2017 in Immunity
Verified
Journal Article
Closed access
NHNorihito Hayatsu
Norihito Hayatsu
TMTakahisa Miyao
Takahisa Miyao
MTMasashi Tachibana
Masashi Tachibana
RMRyuichi Murakami
Ryuichi Murakami
AKAkihiko Kimura
Akihiko Kimura
SHShohei Hori
Shohei Hori

1 May 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KWKoichiro Wada
Koichiro Wada
ANAtsushi Nakajima
Atsushi Nakajima
KKKazufumi Katayama
Kazufumi Katayama
CKChiho Kudo
Chiho Kudo
ASAtsuhito Shibuya
Atsuhito Shibuya
RBRichard S. Blumberg
Richard S. Blumberg
Peroxisome proliferator-activated receptor γ (PPARγ) plays an important role in insulin sensitivity, tissue homeostasis, and regulating cellular functions. We found high-level expression of PPARγ in embryo mouse brain and neural stem cells (NSCs), in contrast to extremely low levels in adult mouse brain. Here, we show that PPARγ mediates the proliferation and differentiation of murine NSCs via up-regulation of the epidermal growth factor receptor and activation of the ERK pathway. Cell growth rates of NSCs prepared from heterozygous PPARγ-deficient mouse brains, PPARγ-RNA-silenced NSCs, and PPARγ dominant-negative NSCs were significantly decreased compared with those of wild-type NSCs. Physiological concentrations of PPARγ agonists, rosiglitazone and pioglitazone, stimulated NSC growth, whereas antagonists caused cell death in a concentration-dependent manner via activation of the caspase cascade. The stimulation of cell growth by PPARγ was associated with a rapid activation of the ERK pathway by phosphorylation and up-regulation of epidermal growth factor receptor and cyclin B protein levels. In contrast, activation of PPARγ by agonists inhibited the differentiation of NSCs into neurons. The inhibition of differentiation was associated with an activation of STAT3. These data indicate that PPARγ regulates the development of the central nervous system during early embryogenesis via control of NSC proliferation.